Patent ID: 11918592
Assignee: SYROS PHARMACEUTICALS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 4:
5. The compound of claim 4 or the pharmaceutically acceptable salt, stereoisomer, or isotopic form thereof, wherein R1 is hydrogen or —CH3, and R6 is hydrogen, —C1-C4 alkyl, halo-substituted —C1-C4 alkyl, hydroxy-substituted —C1-C4 alkyl, or —(C1-C4 alkylene)-O—(C1-C4 alkyl), or R5 and R6 are taken together with the nitrogen atom to which they are bound to form a saturated heterocyclyl optionally substituted with 1-4 substituents independently selected from halo, —OH, —C1-C4 alkyl, and —O—(C1-C4 alkyl).